Clinical trial
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
NCT07641361
Study timeline
Study start (actual)2026-09-24Date precision: day
Registry last updated2026-10-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesity & Overweightunresolved
Type 2 Diabetesunresolved
Type 2 Diabetes (Adult Onset)unresolved
Obesity Type 2 Diabetes Mellitusunresolved
Dehydrationunresolved
Interventions
Hydration PlusBEHAVIORAL
ControlBEHAVIORAL
Sponsors & collaborators
State University of New York at Buffalolead sponsor
National Institutes of Health (NIH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07641361 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.